Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 63 | ECE2019 | Next issue

21st European Congress of Endocrinology

Lyon, France
18 May 2019 - 21 May 2019

Card image cap
18-21 May 2019, Lyon, France

Guided Posters

Diabetes: Pharmacotherapy

Previous section
Adrenal and Neuroendocrine - Clinical
Table of contents
Next section
Gestational and Type 1 Diabetes

ea0063gp200 | Diabetes: Pharmacotherapy

A liver selective knockdown of Dpp4 by therapeutic siRNA affects lipid metabolism but fails to improve glucose control in diabetic mice

ea0063gp201 | Diabetes: Pharmacotherapy

Blood intact incretin levels are related to beta-cell function and glycemia in patients with type 2 diabetes

ea0063gp202 | Diabetes: Pharmacotherapy

The growth hormone effect blocked with pegvisomant did not alter the free fat acid plasma concentration in pre-diebetic or type 2 diabetic patients treated with empagliflozin

ea0063gp203 | Diabetes: Pharmacotherapy

Effects of cardiovascular function of SGLT-2 inhibitos versus DPP–4 inhibitors in type 2 diabetes with coronary artery disease

ea0063gp204 | Diabetes: Pharmacotherapy

Fasting insulin levels correlate with the incidence of hypoglycemic events in patients with Type 2 Diabetes treated with sulfonylureas: a retrospective cross-sectional study

ea0063gp205 | Diabetes: Pharmacotherapy

Metabolic changes in men undergoing androgen deprivation therapy for prostate cancer

ea0063gp206 | Diabetes: Pharmacotherapy

Antioxidant and hypoglycemic effects of gossitan

ea0063gp207 | Diabetes: Pharmacotherapy

Treatment with sitagliptin in patients with type 1 diabetes and type LADA diabetes

ea0063gp208 | Diabetes: Pharmacotherapy

Effects of glucagon-like peptide 1 receptor agonist on short-chain fatty acids, carbohydrate and lipid metabolism in patients with type 2 diabetes

ea0063gp209 | Diabetes: Pharmacotherapy

Efficacy and tolerability of dulaglutide in patients with type 2 diabetes: Experience on a secondary Hospital

ea0063gp210 | Diabetes: Pharmacotherapy

Empagliflozin inhibits apoptosis of pancreatic beta-cells through amelioration of ER-stress.

ea0063gp211 | Diabetes: Pharmacotherapy

New insights on strain-specific impacts of probiotics on insulin resistance

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more